BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 26079490)

  • 21. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
    Ichikawa S; Omiya Y; Onishi H; Motosugi U
    J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
    Errante Y; Cirimele V; Mallio CA; Di Lazzaro V; Zobel BB; Quattrocchi CC
    Invest Radiol; 2014 Oct; 49(10):685-90. PubMed ID: 24872007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
    Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
    Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
    Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
    Kralik SF; Singhal KK; Frank MS; Ladd LM
    AJR Am J Roentgenol; 2018 Nov; 211(5):1063-1067. PubMed ID: 30106613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
    Ichikawa S; Motosugi U; Omiya Y; Onishi H
    Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
    Hu HH; Pokorney A; Towbin RB; Miller JH
    Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
    Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
    Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
    Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
    Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
    Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
    Flood TF; Stence NV; Maloney JA; Mirsky DM
    Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.
    Radbruch A; Haase R; Kickingereder P; Bäumer P; Bickelhaupt S; Paech D; Wick W; Schlemmer HP; Seitz A; Bendszus M
    Radiology; 2017 Jun; 283(3):828-836. PubMed ID: 28273007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
    Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
    Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
    Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
    Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.